Edition:
United Kingdom

People: Aptargroup Inc (ATR.N)

ATR.N on New York Stock Exchange

118.40USD
13 Sep 2019
Change (% chg)

$0.35 (+0.30%)
Prev Close
$118.05
Open
$118.55
Day's High
$118.97
Day's Low
$117.75
Volume
107,085
Avg. Vol
76,505
52-wk High
$125.92
52-wk Low
$88.33

Wu, Jesse 

Mr. Jesse Wu is an Independent Director of the Company . Mr. Wu is an advisor to private equity firms. From 2003 through 2016, Mr. Wu held senior leadership roles at Johnson & Johnson (multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company) including Chairman of Johnson & Johnson China and Worldwide Chairman of the company's Consumer Healthcare Division. Mr. Wu is a director of The a2 Milk Company Limited (an ASX- and NZX-listed company that commercializes intellectual property relating to a2 milk and related products) and Shanghai Kehua Bio-Engineering Co. Ltd. (a SZSE-listed manufacturer of in vitro diagnostic products). Mr. Wu was a director of Li-Ning Company Limited (a SEHK-listed manufacturer of athletic shoes and sporting goods) from August 2015 until March 2018. The Board of Directors concluded that Mr. Wu should continue to serve as a director of Aptar due to his knowledge of and background in consumer products and his international experience, including his extensive experience working in China.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 129,954
Long-Term Incentive Plans, USD --
All Other, USD 82,000
Fiscal Year Total, USD 211,954

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

George Fotiades

315,040

Stephan Tanda

8,039,180

Robert Kuhn

2,683,110

Xiangwei Gong

1,428,480

Marc Prieurvia

--

Eldon Schaffer

1,952,210
As Of  31 Dec 2018